U.S. Personal Products Stock News

Forum Energy Technologies (FET) is back on many investors’ screens as offshore and subsea spending plans, project pipelines, and pricing discipline come under fresh scrutiny, adding volatility to trading in smaller energy technology names. See our latest analysis for Forum Energy Technologies. At a share price of $43.62, Forum Energy Technologies has seen short term momentum build, with a 30 day share price return of 18.69% and a 90 day share price return of 38.04%. The 1 year total...

Reddit (NYSE:RDDT) has entered a new collaboration with Emplifi to connect its community driven data with Emplifi’s customer experience tools. Reddit has expanded Reddit Ads functionality through Invoca, aiming to give brands clearer attribution and call analytics tied to Reddit ad campaigns. These integrations are part of Reddit’s push to serve enterprise clients that want measurable engagement and insight from Reddit’s communities. For investors watching NYSE:RDDT, these moves illustrate...

EBITDA beat and mining restarts put Core Natural Resources in focus Core Natural Resources (CNR) is back on investors’ radar after reporting third quarter adjusted EBITDA of $141 million, resuming longwall mining at Leer South and clearing safety issues at Mountaineer II. See our latest analysis for Core Natural Resources. The stock has eased back from a fresh 52 week high of US$102.99 to around US$99. A 12% 1 month share price return and 23.5% 3 month share price return sit alongside a 3...

Why Avista Stock Is On Investors’ Radar Avista (AVA) is drawing attention after recent share price moves, with a 1 day return of about a 1.3% decline, in contrast with gains over the past month and past 3 months. See our latest analysis for Avista. At the current share price of US$40.04, Avista’s recent 4.05% 30 day share price return and 3.41% year to date share price return contrast with a stronger 14.27% 1 year total shareholder return, suggesting steady but not accelerating momentum. If...

How LGI Homes Stock Has Been Moving LGI Homes (LGIH) has recently seen mixed share performance, with a 3.2% decline over the past day and a 4.8% decline over the past week, alongside a gain over the past month. Over the past 3 months the stock has recorded a gain, while the year-to-date figure is also positive. In contrast, the past year, 3-year, and 5-year total returns all show declines. See our latest analysis for LGI Homes. At a share price of $51.21, LGI Homes has seen short term...

Recently, ZIM Integrated Shipping Services reported that its short interest as a percentage of float fell by 14.99%, to 15.54%, still well above the peer group average of 2.71%. This pullback in short positioning, while remaining elevated versus peers, highlights a shift in sentiment that could be especially important for such a heavily shorted stock. We will now examine how this sharp reduction in short interest shapes ZIM Integrated Shipping Services’ investment narrative and investor...

Palantir Technologies (NasdaqGS:PLTR) has entered a large, multi-year commercial partnership with South Korea's HD Hyundai, covering shipbuilding, construction, robotics, and electric systems. The agreement places Palantir's AI platforms at the center of HD Hyundai's group-wide digital transformation plans. Separately, Palantir is working on sovereign-grade AI data centers across Europe, the Middle East, and Africa for commercial and government use. Palantir, known for its data and AI...

Regeneron Pharmaceuticals (REGN) is back in focus after the approval of its high dose Eylea HD, which cuts injection frequency, combined with continued Dupixent momentum and fresh bullish commentary from analysts and long term shareholders. See our latest analysis for Regeneron Pharmaceuticals. Those Eylea HD and Dupixent updates arrive as Regeneron’s 90 day share price return of 15.14% contrasts with a softer year to date share price return of a 2.93% decline, while the 1 year total...

Arrowhead Pharmaceuticals (ARWR) has drawn fresh attention after China’s NMPA approved its drug Redemplo for familial chylomicronemia syndrome. This marks the therapy’s third clearance, following earlier approvals in the US and Canada. See our latest analysis for Arrowhead Pharmaceuticals. At a share price of US$67.05, Arrowhead has given investors a 69.53% 90 day share price return. The 1 year total shareholder return of 231.11% and 3 year total shareholder return of 101.47% underline how...

On January 22, 2026, Eastern Bankshares reported Q4 2025 earnings that exceeded analyst expectations, detailed higher full-year net interest income of US$828.6 million, and confirmed a regular quarterly cash dividend of US$0.13 per share payable on March 20, 2026 to shareholders of record on March 6, 2026. The company also completed a US$55.4 million buyback of 3,100,000 shares, reported lower net charge-offs of US$9.8 million for Q4 2025, and highlighted record wealth assets under...

L3Harris Technologies has raised its quarterly cash dividend from US$1.20 to US$1.25 per share, and the Pentagon has committed US$1.00 billion to its solid rocket motors business ahead of a planned Missile Solutions spin-off and IPO in the second half of 2026. Together, the higher dividend and the Department of Defense’s direct equity stake highlight L3Harris’s effort to reposition its portfolio around core defense technologies while still emphasizing shareholder returns. We’ll now examine...

Fidelity National Information Services (FIS) recently reshaped its business mix by selling its remaining Worldpay stake and buying Global Payments' issuer solutions arm, while lifting its 2025 revenue and earnings guidance to reflect operational progress. See our latest analysis for Fidelity National Information Services. Even after the recent portfolio reshuffle and upgraded 2025 guidance, the 1-year total shareholder return of 23.71% decline and 5-year total shareholder return of 47.69%...

United Airlines Holdings reported its fourth-quarter 2025 results, with revenue of US$15,397 million and net income of US$1,044 million, alongside record full-year revenue of US$59,070 million and earnings per share of US$10.20. Beyond the headline records, the company’s premium cabins delivered around 12% year-on-year revenue growth, and United became the only US airline to grow earnings per share over the year while also raising guidance for 2026. We’ll now examine how United’s upgraded...

In January 2026, IPG Photonics showcased a broad lineup of new laser solutions at the SPIE Photonics West Exhibition in San Francisco, spanning cleaning, welding, cutting, micro‑machining, semiconductor manufacturing, and directed energy applications. The introduction of ultra‑compact multi‑kilowatt lasers, deep UV and femtosecond sources, and integrated high‑power welding platforms underscores IPG Photonics’ push into higher‑precision manufacturing, defense, and EV battery production...

Why the recent news around West Pharmaceutical Services stock matters West Pharmaceutical Services (WST) has been in focus after recent commentary highlighted expected improvements in earnings estimates, a positive Zacks ranking, and solid demand for its proprietary drug delivery products and capacity expansion plans. See our latest analysis for West Pharmaceutical Services. Despite upbeat commentary around earnings estimates and strong demand for its drug delivery products, the share price...

Pursuit Attractions and Hospitality, Inc. previously announced it had entered into an agreement to sell its Flyover flying theater subsidiaries for US$78.40 million in cash, subject to regulatory approvals and including a US$10.00 million termination fee under certain conditions. This divestiture marks a meaningful reshaping of Pursuit’s attractions portfolio and signals potential capital redeployment within its wider hospitality and attractions businesses. We will now examine how the...

Preliminary 2025 loss guidance and recent share move JinkoSolar Holding (JKS) recently issued preliminary unaudited 2025 earnings guidance, indicating an estimated net loss for Jiangxi Jinko of RMB 5,900 million to RMB 6,900 million, with losses remaining sizeable even after excluding extraordinary items. The guidance followed a volatile stretch for the stock, including a decline over the past week following gains over the past 3 months. It provides investors with a clearer fundamental...

In January 2026, Guardian Pharmacy Services, Inc. reaffirmed its 2025 revenue guidance of US$1.43 billion to US$1.45 billion and issued new 2026 guidance of US$1.40 billion to US$1.42 billion. This updated outlook gives investors a clearer view of expected near-term revenue trends and reflects management’s willingness to quantify its forward plans. Next, we’ll examine how the reaffirmed 2025 outlook and newly issued 2026 revenue range shape Guardian Pharmacy Services’ investment...

Terex Corporation has appointed Namita Jindal as Senior Vice President and Chief AI and Data Officer, effective 19 January 2026, reporting directly to President and CEO Simon Meester and joining the Executive Leadership Team. By bringing in an executive with long experience in digital transformation and industrial automation, Terex is signaling a stronger focus on embedding AI and data into its operations and products. We will now examine how this leadership move, centered on AI and data...

WisdomTree, Inc. recently launched two new exchange-traded funds on Cboe, the WisdomTree Efficient TIPS Plus Gold Fund (GDT) and the WisdomTree Efficient Long/Short U.S. Equity Fund (WTLS), expanding its capital‑efficient lineup with expense ratios of 0.30% and 0.88%, respectively. By pairing inflation-linked Treasuries with gold and applying machine-learning-driven long/short equity overlays, these funds highlight WisdomTree’s focus on combining traditional exposures with innovative tools,...

UnitedHealth’s decision to return Affordable Care Act profits has put sector regulation in focus, raising questions about how any similar measures could reshape Centene (CNC) and its reliance on health exchange earnings. See our latest analysis for Centene. Against the backdrop of potential Affordable Care Act profit rebates, Centene’s share price has climbed, with a 30 day share price return of 13.77% and a 90 day share price return of 38.87%. In contrast, the 1 year total shareholder return...

In its latest reported quarter, Acushnet Holdings, maker of Titleist Pro V1 golf balls, delivered a 6% year-on-year revenue increase and exceeded analyst expectations on both sales and adjusted operating income. This combination of top-line growth and operational outperformance, set against generally resilient leisure products peers, highlighted the company’s ability to execute in a competitive consumer landscape. With recent gains in the share price, we’ll examine how Acushnet’s...

StepStone Group has recently announced plans to release its third-quarter fiscal 2026 results on February 5, 2026, and, through StepStone Real Estate, completed a US$250 million continuation vehicle with Blue Moon Capital Partners to operate and expand a portfolio of Class A senior housing communities. This combination of upcoming earnings disclosure and targeted senior housing expansion highlights how StepStone is positioning within specialized alternative assets alongside experienced...

Intuitive Surgical reported past fourth-quarter 2025 revenue of US$2.87 billion and net income of US$794.8 million, capping a full-year revenue of US$10.06 billion and net income of US$2.86 billion, both higher than the prior year. The company underscored rapid global uptake of its da Vinci 5 and Ion systems, with more than 3.1 million da Vinci procedures in 2025 and over 20 million such surgeries performed worldwide to date. We’ll now examine how this combination of strong earnings and...